Caparen 500 mg (Tablet)
Unit Price: ৳ 125.00 (4 x 6: ৳ 3,000.00)
Strip Price: ৳ 750.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Capecitabine |
| Company | Renata limited |
Title
- Caparen Nucleoside Metabolic Inhibitor
Categories
- Chemotherapy
- Anti-Cancer Medication
- Orally-Administered Chemotherapeutic Agent
Description
- Indicated for Adjuvant Colon Cancer
- First-line as Monotherapy for Metastatic Colorectal Cancer
- In Combination with Docetaxel for Metastatic Breast Cancer
- Converted to Fluorouracil for DNA Synthesis Inhibition and Tumor Growth Slowdown
- Recommended Dosage for Monotherapy, Adjuvant Treatment, and Combination with Docetaxel
- Interactions with Anticoagulants, Phenytoin, Leucovorin, CYP2C9 Substrates, and Food
- Contraindicated in Severe Renal Impairment, Hypersensitivity, Leucopenia, Neutropenia, Thrombocytopenia, Severe Reactions to Fluoropyrimidine Therapy, Complete DPD Deficiency, Pregnancy, and Breastfeeding
- Side Effects such as Abdominal Pain, Rash, Diarrhea, Vomiting, Nausea, Stomatitis, Hand-and-Foot Skin-Reaction, Fever, Infection, and Steven-Johnson Syndrome
- Pregnancy Category D, Risk to Fetus, and Discontinuation of Breastfeeding during Treatment and 2 Weeks After Final Dose
- Precautions for Coagulopathy, Diarrhea, Cardiotoxicity, DPD Activity, Dehydration, Renal Failure, Mucocutaneous and Dermatologic Toxicity, Hyperbilirubinemia, and Hematologic Abnormalities
- Overdose Effects Include Nausea, Vomiting, Diarrhea, Mucositis, Gastrointestinal Irritation and Bleeding, and Bone Marrow Depression
- Belongs to Therapeutic Class Cytotoxic Chemotherapy
- Storage Conditions Below 30°C, Dry Place, Protected from Light, and Out of Reach of Children